77915471 - SELCIA

Information

• Trademark
• 77915471

• Source

• Serial Number

  77915471

• Registration Number

  4266079

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 20, 2010
  14 years ago

• Registration Date

  January 01, 2013
  11 years ago

• Transaction Date

  August 29, 2023
  a year ago

• Status Date

  July 21, 2023
  a year ago

• Published for Opposition Date

  October 16, 2012
  12 years ago

• Renewal Date

  January 01, 2023
  a year ago

• Location Date

  July 21, 2023
  a year ago

• Status Code

  800

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  LAPTER, ALAIN J

• Attorney Docket Number

  60895-284514

  Attorney Name

  Rebecca Liebowitz

  Law Office Assigned Location Code

  L80

• Owners

  • Selcia Ltd.

Case File Statements

• B00001: In the statement, Priority under section 44(d) Application number 8813438 dated January 15, 2010 should be inserted.
• GS0051: (Based on 44(e) Chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as pharmaceuticals for the treatment of infectious diseases, and diseases and disorders in the field of oncology, hepatology, nephrology, cardiovascular, vascular, respiratory, serology, immunology, haematology, metabolism, neurology and neurodegeneration, neuropathies, pain, gastrointestinal, dermatology, muscoskeletal, central nervous system, endocrinology, hormonal, psychiatric, dementia, urology, obstetrics and gynaecology, ophthalmology, inflammation, odontology, dentistry, cognition, genetic disorders, cerebrovascular, eating disorders, hearing, hypothalamic and pituitary diseases, and sleep disorders; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use in pharmaceutical research and drug discovery; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations, being clinical candidates for use in pharmaceutical research and drug discovery; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use in hit identification, lead generation, optimisation and development in pharmaceutical research; diagnostic agents, preparations and substances for medical purposes; radiolabelled ligands and isotopically labelled compounds used in screening and diagnostic tests for medical purposes; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as reference standards of products, impurities and metabolites in pharmaceutical and veterinary industries
• GS0161: (Based on 44(e) Printed matter, namely, leaflets, brochures, labels, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, articles, reports, promotional literature and product guides in the field of science, including chemistry and biology, and in the field of pharmaceutical, medicinal, pesticidal, chemical and laboratory research and development services; presentations in the nature of graphic slides and manuals in the field of science, including chemistry and biology, and in the field of pharmaceutical, medicinal, pesticidal, chemical and laboratory research and development services; printed reports and certificates in the field of pharmaceutical research and development, crop protection and environmental regulatory submissions
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: (Based on 44(e) Services in the provision of chemical and biological compounds for use in research, development and regulatory studies, namely, wholesale distributorship services of chemical compounds; stock management, in the nature of inventory management of chemical compounds
• GS0011: (Based on 44(e) Synthetic, natural and biological chemicals used in industry and science; synthetic, natural and biological chemicals used in agriculture, except fungicides, herbicides and parasitides; synthetic, natural and biological chemical compounds for use as radiotracers; radiolabelled chemical compounds for use in regulatory, research and scientific studies for research purposes; synthetic, natural and biological chemical compounds with isotopic labels for research purposes; synthetic, natural and biological chemical compounds for research purposes; chemical libraries consisting of chemicals for scientific, research and development use; chemical fragment libraries consisting of chemicals for scientific, research and development use; chemical reagents for non-medical purposes; biochemical and biological preparations for use in industry, science and research, except for medical use; diagnostic preparations for scientific, research and development use; radioactive elements, isotopes and preparations for scientific, research and development use, not including therapeutic or diagnostic use; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as reference standards of products, impurities and metabolites in agrochemical and chemical industries
• TR0010: The wording "SELCIA" has no meaning in a foreign language.
• GS0421: (Based on 44(e) Scientific research and development services, and scientific design services in the field of chemical and biological preparation, testing, research and development; scientific consultancy services in the field of chemistry and biology; medicinal chemistry research, development and consultation services; pharmaceutical research services; chemistry research, development and consultation services; synthetic chemistry research, development and consultation services; analytical chemistry research, development and consultation services; natural products chemistry research, development and consultation services; chemical and biological laboratory services; analysis in the field of good laboratory practice; biology research, development and consultation services; cell biology research, development and consultation services; biology research, development and consultation services in lead discovery and optimisation; consultancy services in the field of drug discovery and evaluation; research, development and consultation services in the field of radiolabelling; consultancy services in the field of radiolabelling and radiosynthesis; synthesis and analysis of radiolabelled compounds; research, development and consultation services in the field of stable labelling; research, development and consultation services in the field of fragment based drug discovery, fragment screening and fragment based lead discovery; synthesis and analysis of chemical compounds; provision of analytical chemistry and biology services to support regulatory submissions; provision of certification and analysis of the goods and services of others for regulatory submissions; nuclear magnetic resonance spectroscopy for research, development and laboratory purposes; nuclear magnetic resonance spectroscopy for research, development and laboratory purposes; research, development and consultation services in the field of metabolite synthesis; chemistry and biology services, namely, synthesis of reference standards, process impurities and metabolites; analysis, research and investigation into chemical compounds; analysis, research and investigation into structural elucidation, metabolite identification and spectral interpretation; anti-counterfeiting services for chemical compounds, namely, analysis of chemical and biological compounds for purity measurement; preparation of expert reports and interpretation in the field of chemistry, biology and chemical analysis; services in the provision of information and reports in the field of chemistry, biology and chemical analysis for use in research, development and regulatory studies; scientific data interpretation services; scientific investigation, research, development and analysis in the fields of pharmaceuticals, biotechnology, structural biology, veterinary, animal health, agriculture, pesticides, insecticides, fungicides, herbicides, biocides, food and nutrition, household, personal care, cosmetics and the chemical industry; chemical and biological fragment screening technology research, development and consultation services; electrophoresis research, development and consultation services; capillary electrophoresis research, development and consultation services; chemical and biological screening services for research, development and consultation purposes; fragment based chemical and biological screening services for research, development and consultation purposes; services in the provision of a chemical fragment library, namely, chemical information and materials, and research and development services, provided to research laboratories of others for the design and development of chemical and biological compounds and pharmaceuticals; screening services, namely, development of chemical and biological screens, cell biology and protein expression for research and development purposes; adaptation of technology for the provision of screening data and information; provision of information and data in the field of pharmaceutical research and development; consultancy services in the field of the creation, generation and preparation of research proposals in the field of industrial and scientific research and development; provision of medical chemistry and biology research support; technical support services, namely, providing technical advice; provision of information in the fields of scientific research and design, chemical compounds, medical research, medicinal chemistry, pharmaceutical research, chemistry, synthetic chemistry, analytical chemistry, biology, chemical and biological screening and analysis; provision of reports on good scientific, research and development laboratory practice; computational chemistry research, development and consultation services; informatics services, namely, chemistry and biology informatics and molecular informatics services, namely, data analysis and interpretation; combinatorial chemistry research, development and consultation services; consultancy in relation to all the aforesaid services

Case File Event Statements

• 7/21/2023 - a year ago

  55 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89

• 7/21/2023 - a year ago

  54 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1

• 7/21/2023 - a year ago

  53 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG

• 7/21/2023 - a year ago

  52 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 1/3/2023 - a year ago

  51 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 1/1/2022 - 2 years ago

  50 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 1/14/2019 - 5 years ago

  49 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8

• 1/14/2019 - 5 years ago

  48 - REGISTERED - SEC. 8 (6-YR) ACCEPTED Type: 8.OK

• 1/14/2019 - 5 years ago

  47 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 12/24/2018 - 5 years ago

  46 - TEAS SECTION 8 RECEIVED Type: ES8R

• 1/1/2018 - 6 years ago

  45 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 1/10/2017 - 7 years ago

  44 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/4/2013 - 11 years ago

  43 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.

• 2/1/2013 - 11 years ago

  42 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 1/24/2013 - 11 years ago

  41 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 1/1/2013 - 11 years ago

  40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/16/2012 - 12 years ago

  39 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/26/2012 - 12 years ago

  38 - NOTICE OF PUBLICATION Type: NPUB

• 9/7/2012 - 12 years ago

  37 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/30/2012 - 12 years ago

  36 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 8/29/2012 - 12 years ago

  35 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/29/2012 - 12 years ago

  34 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/29/2012 - 12 years ago

  33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/29/2012 - 12 years ago

  32 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 8/19/2012 - 12 years ago

  31 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 8/7/2012 - 12 years ago

  30 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/3/2012 - 12 years ago

  29 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/2/2012 - 12 years ago

  28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/2/2012 - 12 years ago

  27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/23/2012 - 12 years ago

  26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/7/2012 - 12 years ago

  25 - NON-FINAL ACTION MAILED Type: CNRT

• 2/7/2012 - 12 years ago

  24 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/6/2012 - 12 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/6/2012 - 12 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/13/2012 - 12 years ago

  21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 1/5/2012 - 12 years ago

  20 - FINAL REFUSAL MAILED Type: CNFR

• 1/5/2012 - 12 years ago

  19 - FINAL REFUSAL WRITTEN Type: CNFR

• 12/22/2011 - 12 years ago

  18 - ASSIGNED TO EXAMINER Type: DOCK

• 12/7/2011 - 12 years ago

  17 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 12/7/2011 - 12 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/22/2011 - 12 years ago

  15 - PAPER RECEIVED Type: MAIL

• 5/23/2011 - 13 years ago

  14 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI

• 5/23/2011 - 13 years ago

  13 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 5/5/2011 - 13 years ago

  12 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK

• 5/2/2011 - 13 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 11/1/2010 - 14 years ago

  10 - LETTER OF SUSPENSION MAILED Type: CNSL

• 11/1/2010 - 14 years ago

  9 - SUSPENSION LETTER WRITTEN Type: CNSL

• 10/25/2010 - 14 years ago

  8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/25/2010 - 14 years ago

  7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/25/2010 - 14 years ago

  6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/26/2010 - 14 years ago

  5 - NON-FINAL ACTION MAILED Type: CNRT

• 4/26/2010 - 14 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/19/2010 - 14 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/25/2010 - 14 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/23/2010 - 14 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP